A Phase I Clinical Trial of MEK162 in Combination With FOLFOX in Patients With Advanced Metastatic Colorectal Cancer Who Failed Prior Standard Therapy
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2018
Price : $35 *
At a glance
- Drugs Binimetinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- 23 Jan 2018 Status changed from active, no longer recruiting to completed.
- 09 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Nov 2018.
- 09 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Nov 2018.